Article

Molecular rationale for antibody-mediated targeting of the hantavirus fusion glycoprotein

eLife · 2020 · Ilona Rissanen, author ([email protected]) Robert Stass, author Stefanie A Krumm, author Jeffrey Seow, author Ruben JG Hulswit, author Guido C Paesen, author Jussi Hepojoki, author Olli Vapalahti, author Åke Lundkvist, author Olivier Reynard, author Viktor Volchkov, author Katie J Doores, author Juha T Huiskonen, author Thomas A Bowden, author ([email protected]) Pamela J Bjorkman, editor José D Faraldo-Gómez, senior_editor

Key facts

Title Molecular rationale for antibody-mediated targeting of the hantavirus fusion glycoprotein
First author Ilona Rissanen, author ([email protected]) Robert Stass, author Stefanie A Krumm, author Jeffrey Seow, author Ruben JG Hulswit, author Guido C Paesen, author Jussi Hepojoki, author Olli Vapalahti, author Åke Lundkvist, author Olivier Reynard, author Viktor Volchkov, author Katie J Doores, author Juha T Huiskonen, author Thomas A Bowden, author ([email protected]) Pamela J Bjorkman, editor José D Faraldo-Gómez, senior_editor
Journal eLife
Published Dec 22, 2020
DOI 10.7554/eLife.58242
Devices mentioned BK110039, K042152, K940422, K982100
Product codes mentioned CFN, DFZ, PCA, JJH

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature